The South Korean conglomerate invested $350 million in King of Prussia's Center for Breakthrough Medicines in December 2021.
The South Korean conglomerate invested $350 million in King of Prussia's Center for Breakthrough Medicines in December 2021.
About Our Site:
The primary purpose of the site is to provide Real Estate & Mortgage information as it relates to today’s business environment. It can also be used to answer related question you might have about buying, selling, or financing real estate.